The medical cannabis provider fighting for fairer access for UK patients
Ben Langley, founder and CEO of the Grow Group, a biopharmaceutical company focused solely on cannabis based medicines and improving global access to those medicine
Ben Langley, founder and CEO of the Grow Group, a biopharmaceutical company focused solely on cannabis based medicines and improving global access to those medicine
Most Canadian pediatricians are shying away from medical cannabis for patients, knowing that it can hurt the developing brain and that there isn’t much research to guide them.